NCT07328269 Effects of Mulligan Mobilization in Comparison With Maitland Mobilization in Temporomandibular Joint Dysfunction.
| NCT ID | NCT07328269 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Foundation University Islamabad |
| Condition | Temporomandibular Joint Dysfunction |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-09-05 |
| Primary Completion | 2025-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-09-05 with a primary completion date of 2025-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The temporomandibular joint dysfunction is the second most common musculoskeletal pain after back pain, causing jaw pain, restricted movement, and joint sounds. NPRS and millimeter ruler will be used for the assessment of patient. This study will compare the effects of Mulligan and Maitland mobilization, commonly used treatment, on pain and Temporomandibular joint mobility through a randomized controlled trial, involving 30 participants divided into two groups for treatment.
Eligibility Criteria
Inclusion criteria * Age 19-44 years. * Both Genders (Male and Female). * Patients diagnosed with TMJ hypomobility using the Manual Functional Analysis questionnaire based on DC/TMD criteria. * Individuals with myofascial pain, scoring above 5 on the NRS and pain upon palpation of at least two of eight masticatory and neck muscles. * Subjects with acute TMD and myofascial pain unrelated to active inflammation, infection, or recent trauma for at least six months. Exclusion criteria * Hypermobility of TMJs. * Pregnancy. * History of rheumatic and inflammatory diseases. * A history of temporomandibular disorders treatment within last three months. * Acute trauma or injuries of face, head or cervical spine, neurological disorders, taking medication that could affect the musculoskeletal system.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07328269 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, up to 44 Years, studying Temporomandibular Joint Dysfunction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07328269 currently recruiting?
Yes, NCT07328269 is actively recruiting participants. Contact the research team at mahnoorbasharat33@gmail.com for enrollment information.
Where is the NCT07328269 trial being conducted?
This trial is being conducted at Islamabad, Pakistan.
Who is sponsoring the NCT07328269 clinical trial?
NCT07328269 is sponsored by Foundation University Islamabad. The trial plans to enroll 30 participants.